Cahal, Adzmaira C.
HRN: 26-42-63 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/26/2024
MUPIROCIN 2%, 15G (TUBE)
12/26/2024
01/02/2025
TOPICAL
Apply
Bid
Abrasions
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes